Virtual Medicinal Product (VMP) - Upadacitinib 30mg modified-release tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Upadacitinib 30mg modified-release tablets | Start Date 07-09-2021 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Modified-release tablet
- Ontology Form/Route
- tabletmodified-release.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L04AF03
- BNF Codes
-
- BNF code 10010300
| Code | Start Date | End Date |
|---|---|---|
| 40087811000001102 | 07-09-2021 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Upadacitinib hemihydrate | Based on Base Substance | Upadacitinib | 30 mg |
Name
Upadacitinib hemihydrate
Basis of strength description
Based on Base Substance
BOSS
Upadacitinib
Strength and UOM (Nmr)
30.0
Strength and UOM (Dmr)
Parent Products
-
VTMUpadacitinib
-
VMP(Current) Upadacitinib 30mg modified-release t...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 28 tablet |